REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/10/2026
Back to search
Official data from USPTO
ALZPROTECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ALZPROTECT
ST13
US500000079292735Class
1, 5, 42, 44
Filing
79292735
Registration
6443519
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/10/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
07/17/2020
Registration date
08/10/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/10/2021
Last transaction
08/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
ANKRAH, NAAKWAMA S
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ALZPROTECT
Representatives
John J. O'Malley Volpe Koenig
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations for science or research; diagnostic products for science or research; diagnostic reagents for science or research; active chemical ingredients for use in the manufacture of medicines for Alzheimer's disease; active synthetic organic chemical products and/or reagents used in the manufacture of medicamentsespecially for the treatment of neurodegenerative diseases such as Alzheimer's diseaseamyloidopathiestauopathies and synucleopathies; synthetic organic chemical products and/or reagents used in the manufacture of veterinary products; synthetic organic chemicals for use in industry and science; chemical reagents other than for medical or veterinary use; vitamins for the manufacture of food supplements
Class 5
Pharmaceutical products for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's diseaseamyloidopathiestauopathies and synucleopathies; medicines; active ingredients of medicines for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's diseaseamyloidopathiestauopathies and synucleopathies; diagnostic agents for medical use; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; diagnostic agents for veterinary use; diagnostic preparations for veterinary use; dietetic foods adapted for medical use; dietetic foodstuffs adapted for veterinary use; food supplements; chemical preparations for medical use namely for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's diseaseamyloidopathiestauopathies and synucleopathies ; chemical preparations for pharmaceutical use namely for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's diseaseamyloidopathiestauopathies and synucleopathies; medicinal herbs; herbal teas for medicinal purposes; food supplements consisting of vitamins; vitamin supplements; vitamin preparations; dietetic preparations adapted for medical purposes and food supplements; dietetic food supplements based primarily on vitamins adapted for medical purposes; dietetic food preparations adapted for medical purpose; medicated food supplements; nutritional and food supplements; vitamin and mineral supplements; vitamin preparations; nutritional supplements consisting primarily of vitamins or minerals for medical use; vitamins and minerals; nutraceuticals for use as a dietary supplement for therapeutic use; nutraceutical preparations for use as a dietary supplement for therapeutic or medical use; nutraceutical products used as dietary supplements
Class 42
Evaluationsestimates and research in the scientific and technological fields of therapeutic treatment and/or prevention of neurodegenerative diseases such as Alzheimer's diseaseamyloidopathiestauopathies and synucleopathiesprovided by engineers or researchers; research and product development in the field of diagnostic products and preparations; research and development of pharmaceutical products and preparations; research and development of medicines; medicine discovery services in the nature of development of pharmaceutical preparations; engineering services in the form of technical evaluations concerning design for quality control concerning design of new pharmaceutical products; scientific research; technical research in the field of pharmaceutical studies; research and development of new products for third parties; conducting of technical project studies namelytechnological research in the field of medical instruments
Class 44
Medical diagnostic services for diagnostic and treatment purposes provided by medical laboratories; medical services; hospital services; alternative medicine services; providing nutrition information
Publications
History of USPTO decisions and trademark events.
25 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/06/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/18/2022
FIMP
FINAL DISPOSITION PROCESSED
01/18/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/10/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/25/2021
PUBO
PUBLISHED FOR OPPOSITION
05/25/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/23/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/05/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/05/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/20/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/20/2021
RFNT
REFUSAL PROCESSED BY IB
12/13/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/23/2020
RFRR
REFUSAL PROCESSED BY MPU
11/23/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/05/2020
CNRT
NON-FINAL ACTION WRITTEN
11/04/2020
DOCK
ASSIGNED TO EXAMINER
11/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
09/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/04/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/03/2020
Continuous trademark protection
Get notified about every new filing that threatens ALZPROTECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.